Disseminated Candidal Infections and Intravenous Hydrocortisone in Preterm Infants

Abstract

We conclude that the administration of i.v. HC significantly increases the risk of DCI in susceptible preterm infants younger than 35 days of age. The potentially serious risks of DCI should be considered particularly in the patient selection process for administration of i.v. HC.